20/09/22
New RNS Announcement:
Interim Results
Recent announcements:£2.2m neurodegenerative disease trial contract
Alzheimer’s Disease Validation for NeuroVocalix
UK Headquarters
Cambridge Cognition Ltd
Tunbridge Court, Tunbridge Lane
Bottisham, Cambridge
CB25 9TU
Tel +44 (0)1223 810700
Email[email protected]
US Headquarters
Cambridge Cognition Ltd
Cambridge Innovation Center
One Broadway, Cambridge
MA, 02142
Tel +1 (617) 859 6499
Email [email protected]
Forward this newsletter